Thrombosis risk in the trauma patient. Prevention and treatment.
Hypercoagulability is frequently seen in the trauma patients. Debate continues over the best method of prophylaxis, diagnosis, and treatment for the trauma patient. From experience with orthopedic and general surgery patients, much has been learned about prophylaxis and diagnosis, and as treatment protocols have been taken from internal medicine literature. Universal guidelines relating specifically to the trauma patient have not, however, been established. Overall, most of the literature suggests using LMWH for the prophylaxis of trauma patients. When LMWH is contraindicated, SCD should be used, with AVFP as a second choice. Surveillance screening for DVT remains controversial, but surveillance before transfer to extended care facilities has proven beneficial. Finally, when DVT is diagnosed, treatment should be initiated as soon as possible and should be continued until the DVT has resolved. Long-term anticoagulation therapy or use of caval filters may be necessary to prevent the morbidity of PE or thrombophlebitic syndrome.
Kelsey
L J
LJ
Spectrum Health Hospital Systems, Grand Rapids, Michigan, USA.
Fry
D M
DM
VanderKolk
W E
WE
D001783:Blood Flow Velocity; D004864:Equipment and Supplies; D005528:Foot / Q000098:blood supply; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D010507:Periodicity; D011312:Pressure; D011655:Pulmonary Embolism / Q000209:etiology; D012307:Risk Factors; D020246:Venous Thrombosis / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control* / Q000628:therapy*; D014947:Wounds and Injuries / Q000150:complications*
D006495:Heparin, Low-Molecular-Weight